M.u.t. AG, a provider of spectrometer, lab automation and OEM solutions, issued its IPO in July on the Entry Standard segment of the German Stock Exchange at €10.25 ($13.88) per share to raise €10.2 million ($13.8 million). In the first half of 2006, the company reported revenues of €6.37 million ($8.63 million). Electronic components company Molexa acquired Polymicro Technologies, a manufacturer of silica capillary tubing, optical fibers and microcomponents for analytical instrumentation, in July. Analytik Jena AG appointed MEP Instruments as its exclusive distributor for Australia and New Zealand. Sartorius AG officially started operations at its new Beijing, China, plant in September. The plant doubles the company’s Chinese production capacity to more than 8,000 sq. m (86,111 sq. ft.) and represents an investment of around €10 million ($13.9 million). Sartorius employs approximately 200 people in China. Smiths Group acquired Sartorius AG’s Sartorius Bearing Technology GmbH business, a manufacturer of hydrodynamic bearings, in October for €20 million ($28.4 million) in cash. Michrom Bioresources named ProteoMass Australia as its exclusive distributor for Australia and New Zealand. MDS Analytical Technologies reported that fiscal third quarter sales grew 92% to $127 million (see IBO 9/15/07), or 11% growth on an organic basis. Adjusted EBITDA rose 140%, or 73% organically, to $36 million. Sciex revenue grew 9% to $72 million, with mass spectrometry end-user revenue up 10%, and the business contributed $21 million in adjusted EBITDA. Molecular Devices sales grew 16% to $55 million in sales and it contributed $15 million in adjusted EBITDA. Within its Molecular and Cell Biology Division, Applied Biosystems named Shaf Yousaf, formerly with Sigma-Aldrich, president of MCB Systems and Peter M. Dansky, previously vice president of Marketing for Arcturus, president of MDB Consumables. Roche Diagnostics appointed Jürgen Schwiezer, president of EMEA (Europe, Middle East, Africa) region and Latin America, as CEO effective January 1, 2008. Roche Diagnostics Applied Science’s nine-month revenue rose 10% to €498 million ($706.3 million) to make up 7.0% of Roche’s total revenues. North American sales grew 10% to 39.8% of revenue, EMEA sales rose 6% to 42.2% of sales and Rest of World sales increased 18%. Third quarter sales rose 11% to €167 million ($236.8 million). Thermo Fisher Scientific will construct an $11 million BioCenter in Logan, Utah, at the site of its bioprocess production business unit. The Center will manufacture single-use bioprocess containers and related products in the HyClone BPC line. The first phase of the project, a 37,000 sq. ft. facility, is expected to be finished by fall 2008. A 94,000 sq. ft. center will be finished over four years and create 75 new jobs.